Cargando…
PMON51 A Single Multipurpose FSH–Blocking Therapeutic for Osteoporosis, Obesity and Alzheimer's Disease
Pharmacological and genetic studies over the past decade suggest that FSH is an actionable target for diseases affecting millions, notably osteoporosis, obesity and Alzheimer's disease (AD). Blocking FSH action prevents bone loss (1, 2), fat and energy metabolism (3) and AD–like features in mic...
Autores principales: | Korkmaz, Funda, Kuo, Tan-Chun, Gera, Sakshi, Sant, Damini, DeMambro, Victoria, Gumerova, Anisa, Sudha, Kathayani, Padilla, Ashley, Netto, Jessica, Sultana, Farhath, Miyashita, Sari, Shelly, Eleanor, Kumar, Pushkar, Burgess, Jocoll, Kannangara, Hasni, Muradova, Valeriia, Hutchison, Susan, Saxena, Mansi, Ryu, Vitaly, Kim, Se-Min, Meseck, Marcia, Goosens, Ki, Rosen, Cliff, Lizneva, Daria, Yuen, Tony, Zaidi, Mone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628713/ http://dx.doi.org/10.1210/jendso/bvac150.1829 |
Ejemplares similares
-
RF10 | PMON205 LH/CG Receptor Activation Protects Mice from Diet-Induced Obesity and Modifies Adipose Tissue Immune Response
por: Lizneva, Daria, et al.
Publicado: (2022) -
FSH-blocking therapeutic for osteoporosis
por: Gera, Sakshi, et al.
Publicado: (2022) -
SAT668 Can We Treat Osteoporosis, Obesity And Neurodegeneration With A Single FSH-blocking Drug?
por: Rani Pallapati, Anusha Rani, et al.
Publicado: (2023) -
SAT669 Development And Biophysical Characterization Of A Humanized FSH-blocking Monoclonal Antibody Therapeutic Formulated At An Ultra-high Concentration
por: Rojekar, Satish, et al.
Publicado: (2023) -
SAT600 Absent LH Signaling Rescues The Anxiety Phenotype In Aging Female Mice
por: Sims, Steven, et al.
Publicado: (2023)